As BPaL loses patent fight, doctors urge caution
MUMBAI: Two days after the Indian Patent Office rejected the patent application of the US-based Global Alliance for TB Drug Development, or TB Alliance, for BPaL, a combination regimen for drug-resistant tuberculosis, doctors say this does not necessarily mean easy access to the medication
Read original article on Mumbai News Live Today, Rain Alerts & Mumbai Headlines Today | Hindustan Times | Hindustan Times →